Symbols / DXCM Stock $62.89 -0.82% DexCom, Inc.
DXCM (Stock) Chart
About
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Stock Fundamentals
Scroll to Statements| Market Cap | 24.27B | Enterprise Value | 23.80B | Income | 836.30M | Sales | 4.66B | Book/sh | 7.14 | Cash/sh | 5.19 |
| Dividend Yield | — | Payout | 0.00% | Employees | 11000 | IPO | — | P/E | 30.09 | Forward P/E | 21.03 |
| PEG | 1.41 | P/S | 5.21 | P/B | 8.81 | P/C | — | EV/EBITDA | 20.45 | EV/Sales | 5.11 |
| Quick Ratio | 1.53 | Current Ratio | 1.88 | Debt/Eq | 50.85 | LT Debt/Eq | — | EPS (ttm) | 2.09 | EPS next Y | 2.99 |
| EPS Growth | 78.00% | Revenue Growth | 13.10% | Earnings | 2026-04-30 | ROA | 8.89% | ROE | 34.50% | ROIC | — |
| Gross Margin | 60.10% | Oper. Margin | 25.64% | Profit Margin | 17.94% | Shs Outstand | 385.87M | Shs Float | 382.94M | Short Float | 4.93% |
| Short Ratio | 3.77 | Short Interest | — | 52W High | 89.98 | 52W Low | 54.11 | Beta | 1.56 | Avg Volume | 4.54M |
| Volume | 709.65K | Target Price | $86.88 | Recom | Strong_buy | Prev Close | $63.41 | Price | $62.89 | Change | -0.82% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-03-11 | main | Citigroup | Buy → Buy | $84 |
| 2026-03-09 | reit | BTIG | Buy → Buy | $85 |
| 2026-02-25 | reit | BTIG | Buy → Buy | $85 |
| 2026-02-17 | reit | Truist Securities | Buy → Buy | $80 |
| 2026-02-13 | main | Canaccord Genuity | Buy → Buy | $95 |
| 2026-02-13 | main | Barclays | Underweight → Underweight | $72 |
| 2026-02-13 | main | Wells Fargo | Overweight → Overweight | $85 |
| 2026-02-13 | main | Mizuho | Outperform → Outperform | $90 |
| 2026-02-13 | reit | BTIG | Buy → Buy | $85 |
| 2026-01-12 | down | Barclays | Equal-Weight → Underweight | $71 |
| 2026-01-09 | main | Bernstein | Outperform → Outperform | $86 |
| 2025-12-17 | main | Mizuho | Outperform → Outperform | $78 |
| 2025-12-11 | main | Citigroup | Buy → Buy | $77 |
| 2025-12-02 | up | Morgan Stanley | Equal-Weight → Overweight | $75 |
| 2025-11-25 | init | Evercore ISI Group | — → In-Line | $68 |
| 2025-11-10 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $63 |
| 2025-11-07 | main | Argus Research | Buy → Buy | $90 |
| 2025-11-03 | main | UBS | Buy → Buy | $95 |
| 2025-11-03 | reit | Truist Securities | Buy → Buy | $82 |
| 2025-11-03 | main | Barclays | Equal-Weight → Equal-Weight | $80 |
- DexCom, Inc. (DXCM) Stock Analysis: Strong Buy Ratings And A 35.78% Potential Upside - DirectorsTalk Interviews Mon, 20 Apr 2026 09
- Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom - The Motley Fool Mon, 20 Apr 2026 21
- A Look At Dexcom (DXCM) Valuation As Shares Lag And Fair Value Estimates Point Higher - Yahoo Finance ue, 21 Apr 2026 10
- Lobbying Update: $75,000 of DEXCOM lobbying was just disclosed - Quiver Quantitative Sat, 18 Apr 2026 17
- TD Cowen reiterates DexCom stock Buy rating on margin expansion outlook - Investing.com hu, 02 Apr 2026 07
- DexCom’s Q1 2026 Earnings Might Change The Case For Investing In DexCom (DXCM) - simplywall.st ue, 21 Apr 2026 14
- A Look at DexCom Inc (DXCM) After 3.1% Decline -- GF Value $109. - GuruFocus Wed, 22 Apr 2026 00
- DXCM 260417 59.00C (DXCM260417C59000) Stock Options Chain | Quotes & News - Moomoo ue, 21 Apr 2026 16
- Dexcom to post first-quarter results after the close on April 30 - Stock Titan hu, 02 Apr 2026 07
- DexCom Inc. (DXCM) - Valuation Disparity Widens Amid Short-Term Price Weakness And Long-Term Growth Catalysts - Cổng thông tin điện tử tỉnh Lào Cai Wed, 22 Apr 2026 01
- DexCom Inc. (DXCM) - Valuation Disparity Widens Amid Short-Term Price Weakness And Long-Term Growth Catalysts - Cost Structure - Xã Thanh Hà Wed, 22 Apr 2026 01
- DexCom (DXCM) Stock Is Up, What You Need To Know - Yahoo Finance Mon, 03 Nov 2025 08
- 2 Healthcare Stocks That Could Outperform the Market Over the Next Decade - The Motley Fool hu, 16 Apr 2026 23
- DexCom Stock Declines Following Strong Preliminary Q4 Results - Yahoo Finance Fri, 16 Jan 2026 08
- DEXCOM INC ($DXCM) President & CEO 2025 Pay Revealed - Quiver Quantitative Wed, 15 Apr 2026 21
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
4,662.00
+15.60%
|
4,033.00
+11.34%
|
3,622.30
+24.49%
|
2,909.80
|
| Operating Revenue |
|
4,662.00
+15.60%
|
4,033.00
+11.34%
|
3,622.30
+24.49%
|
2,909.80
|
| Cost Of Revenue |
|
1,860.10
+16.64%
|
1,594.80
+19.60%
|
1,333.40
+29.87%
|
1,026.70
|
| Reconciled Cost Of Revenue |
|
1,860.10
+16.64%
|
1,594.80
+19.60%
|
1,333.40
+29.87%
|
1,026.70
|
| Gross Profit |
|
2,801.90
+14.92%
|
2,438.20
+6.52%
|
2,288.90
+21.55%
|
1,883.10
|
| Operating Expense |
|
1,890.10
+2.82%
|
1,838.20
+8.69%
|
1,691.20
+13.36%
|
1,491.90
|
| Research And Development |
|
599.10
+8.45%
|
552.40
+9.21%
|
505.80
+4.46%
|
484.20
|
| Selling General And Administration |
|
1,291.00
+0.40%
|
1,285.80
+8.47%
|
1,185.40
+17.63%
|
1,007.70
|
| Total Expenses |
|
3,750.20
+9.24%
|
3,433.00
+13.50%
|
3,024.60
+20.09%
|
2,518.60
|
| Operating Income |
|
911.80
+51.97%
|
600.00
+0.38%
|
597.70
+52.79%
|
391.20
|
| Total Operating Income As Reported |
|
911.80
+51.97%
|
600.00
+0.38%
|
597.70
+52.79%
|
391.20
|
| EBITDA |
|
1,358.50
+43.65%
|
945.70
+3.16%
|
916.70
+62.16%
|
565.30
|
| Normalized EBITDA |
|
1,358.50
+43.65%
|
945.70
+3.16%
|
916.70
+62.16%
|
565.30
|
| Reconciled Depreciation |
|
251.80
+15.66%
|
217.70
+17.04%
|
186.00
+19.31%
|
155.90
|
| EBIT |
|
1,106.70
+52.02%
|
728.00
-0.37%
|
730.70
+78.48%
|
409.40
|
| Total Unusual Items |
|
—
|
—
|
0.00
|
0.00
|
| Total Unusual Items Excluding Goodwill |
|
—
|
—
|
0.00
|
0.00
|
| Special Income Charges |
|
—
|
—
|
0.00
|
0.00
|
| Other Special Charges |
|
—
|
—
|
—
|
—
|
| Net Income |
|
836.30
+45.14%
|
576.20
+6.41%
|
541.50
+58.70%
|
341.20
|
| Pretax Income |
|
1,088.40
+53.51%
|
709.00
-0.20%
|
710.40
+81.78%
|
390.80
|
| Net Non Operating Interest Income Expense |
|
94.40
-18.06%
|
115.20
+0.44%
|
114.70
+2105.77%
|
5.20
|
| Interest Expense Non Operating |
|
18.30
-3.68%
|
19.00
-6.40%
|
20.30
+9.14%
|
18.60
|
| Net Interest Income |
|
94.40
-18.06%
|
115.20
+0.44%
|
114.70
+2105.77%
|
5.20
|
| Interest Expense |
|
18.30
-3.68%
|
19.00
-6.40%
|
20.30
+9.14%
|
18.60
|
| Interest Income Non Operating |
|
112.70
-16.02%
|
134.20
-0.59%
|
135.00
+467.23%
|
23.80
|
| Interest Income |
|
112.70
-16.02%
|
134.20
-0.59%
|
135.00
+467.23%
|
23.80
|
| Other Income Expense |
|
82.20
+1425.81%
|
-6.20
-210.00%
|
-2.00
+64.29%
|
-5.60
|
| Other Non Operating Income Expenses |
|
4.10
+185.42%
|
-4.80
-23.08%
|
-3.90
+30.36%
|
-5.60
|
| Tax Provision |
|
252.10
+89.83%
|
132.80
-21.37%
|
168.90
+240.52%
|
49.60
|
| Tax Rate For Calcs |
|
0.00
+23.86%
|
0.00
-21.22%
|
0.00
+87.33%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
836.30
+45.14%
|
576.20
+6.41%
|
541.50
+58.70%
|
341.20
|
| Net Income From Continuing Operation Net Minority Interest |
|
836.30
+45.14%
|
576.20
+6.41%
|
541.50
+58.70%
|
341.20
|
| Net Income From Continuing And Discontinued Operation |
|
836.30
+45.14%
|
576.20
+6.41%
|
541.50
+58.70%
|
341.20
|
| Net Income Continuous Operations |
|
836.30
+45.14%
|
576.20
+6.41%
|
541.50
+58.70%
|
341.20
|
| Normalized Income |
|
836.30
+45.14%
|
576.20
+6.41%
|
541.50
+58.70%
|
341.20
|
| Net Income Common Stockholders |
|
836.30
+45.14%
|
576.20
+6.41%
|
541.50
+58.70%
|
341.20
|
| Diluted EPS |
|
2.09
+47.18%
|
1.42
+9.23%
|
1.30
+58.54%
|
0.82
|
| Basic EPS |
|
2.14
+46.58%
|
1.46
+4.29%
|
1.40
+59.09%
|
0.88
|
| Basic Average Shares |
|
390.20
-0.86%
|
393.60
+1.97%
|
386.00
-0.87%
|
389.40
|
| Diluted Average Shares |
|
405.50
-1.74%
|
412.70
-3.01%
|
425.50
-0.47%
|
427.50
|
| Diluted NI Availto Com Stockholders |
|
847.30
+44.17%
|
587.70
+6.06%
|
554.10
+57.33%
|
352.20
|
| Average Dilution Earnings |
|
11.00
-4.35%
|
11.50
-8.73%
|
12.60
+14.55%
|
11.00
|
| Amortization |
|
—
|
—
|
—
|
7.50
|
| Amortization Of Intangibles Income Statement |
|
—
|
—
|
—
|
7.50
|
| Depreciation Amortization Depletion Income Statement |
|
—
|
—
|
—
|
7.50
|
| Depreciation And Amortization In Income Statement |
|
—
|
—
|
—
|
7.50
|
| Earnings From Equity Interest |
|
78.10
+5678.57%
|
-1.40
-173.68%
|
1.90
+850.00%
|
0.20
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
6,339.90
-2.23%
|
6,484.50
+3.51%
|
6,264.50
+16.19%
|
5,391.70
|
| Current Assets |
|
4,033.30
-6.23%
|
4,301.40
-2.81%
|
4,425.90
+20.64%
|
3,668.80
|
| Cash And Cash Equivalents |
|
917.70
+51.41%
|
606.10
+7.03%
|
566.30
-11.83%
|
642.30
|
| Other Short Term Investments |
|
1,081.00
-45.22%
|
1,973.30
-8.55%
|
2,157.80
+18.96%
|
1,813.90
|
| Receivables |
|
1,289.90
+23.53%
|
1,044.20
+5.74%
|
987.50
+31.28%
|
752.20
|
| Accounts Receivable |
|
1,216.10
+20.92%
|
1,005.70
+3.27%
|
973.90
+36.53%
|
713.30
|
| Gross Accounts Receivable |
|
1,228.60
+21.06%
|
1,014.90
+3.22%
|
983.20
+36.44%
|
720.60
|
| Allowance For Doubtful Accounts Receivable |
|
-12.50
-35.87%
|
-9.20
+1.08%
|
-9.30
-27.40%
|
-7.30
|
| Taxes Receivable |
|
73.80
+91.69%
|
38.50
+183.09%
|
13.60
-65.04%
|
38.90
|
| Inventory |
|
629.10
+15.94%
|
542.60
-3.04%
|
559.60
+82.46%
|
306.70
|
| Raw Materials |
|
257.60
-21.25%
|
327.10
+2.38%
|
319.50
+100.94%
|
159.00
|
| Work In Process |
|
105.00
+273.67%
|
28.10
-6.33%
|
30.00
+74.42%
|
17.20
|
| Finished Goods |
|
266.50
+42.21%
|
187.40
-10.80%
|
210.10
+61.00%
|
130.50
|
| Prepaid Assets |
|
66.40
-24.11%
|
87.50
-2.99%
|
90.20
-22.71%
|
116.70
|
| Current Deferred Assets |
|
20.00
+7.53%
|
18.60
+22.37%
|
15.20
+49.02%
|
10.20
|
| Other Current Assets |
|
29.20
+0.34%
|
29.10
-40.97%
|
49.30
+83.96%
|
26.80
|
| Total Non Current Assets |
|
2,306.60
+5.66%
|
2,183.10
+18.74%
|
1,838.60
+6.72%
|
1,722.90
|
| Net PPE |
|
1,637.30
+16.72%
|
1,402.70
+18.42%
|
1,184.50
+4.31%
|
1,135.60
|
| Gross PPE |
|
2,496.10
+19.95%
|
2,081.00
+22.85%
|
1,693.90
+13.02%
|
1,498.80
|
| Accumulated Depreciation |
|
-858.80
-26.61%
|
-678.30
-33.16%
|
-509.40
-40.25%
|
-363.20
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Land And Improvements |
|
58.30
+9.79%
|
53.10
+53.91%
|
34.50
+28.25%
|
26.90
|
| Buildings And Improvements |
|
319.70
+9.86%
|
291.00
+52.76%
|
190.50
+250.83%
|
54.30
|
| Machinery Furniture Equipment |
|
1,145.10
+11.64%
|
1,025.70
+30.50%
|
786.00
+48.13%
|
530.60
|
| Construction In Progress |
|
593.50
+67.37%
|
354.60
+8.08%
|
328.10
-39.53%
|
542.60
|
| Other Properties |
|
77.40
+23.25%
|
62.80
-12.04%
|
71.40
-10.75%
|
80.00
|
| Leases |
|
302.10
+2.83%
|
293.80
+3.67%
|
283.40
+7.19%
|
264.40
|
| Goodwill And Other Intangible Assets |
|
95.00
-24.72%
|
126.20
-20.98%
|
159.70
-19.75%
|
199.00
|
| Goodwill |
|
24.20
+6.14%
|
22.80
-9.52%
|
25.20
-1.95%
|
25.70
|
| Other Intangible Assets |
|
70.80
-31.53%
|
103.40
-23.12%
|
134.50
-22.39%
|
173.30
|
| Investments And Advances |
|
218.00
+82.73%
|
119.30
+209.87%
|
38.50
+102.63%
|
19.00
|
| Non Current Deferred Assets |
|
295.60
-38.57%
|
481.20
+14.74%
|
419.40
+22.92%
|
341.20
|
| Non Current Deferred Taxes Assets |
|
295.60
-38.57%
|
481.20
+14.74%
|
419.40
+22.92%
|
341.20
|
| Non Current Prepaid Assets |
|
17.20
+24.64%
|
13.80
-4.17%
|
14.40
-11.11%
|
16.20
|
| Other Non Current Assets |
|
43.50
+9.02%
|
39.90
+80.54%
|
22.10
+85.71%
|
11.90
|
| Total Liabilities Net Minority Interest |
|
3,593.90
-17.98%
|
4,381.90
+4.43%
|
4,195.90
+28.71%
|
3,259.90
|
| Current Liabilities |
|
2,142.50
-26.93%
|
2,932.00
+88.43%
|
1,556.00
-15.40%
|
1,839.30
|
| Payables And Accrued Expenses |
|
2,058.60
+25.45%
|
1,641.00
+11.63%
|
1,470.10
+48.74%
|
988.40
|
| Payables |
|
380.20
-1.91%
|
387.60
+18.71%
|
326.50
+15.49%
|
282.70
|
| Accounts Payable |
|
344.30
-0.29%
|
345.30
+24.93%
|
276.40
+16.18%
|
237.90
|
| Current Accrued Expenses |
|
1,678.40
+33.91%
|
1,253.40
+9.60%
|
1,143.60
+62.05%
|
705.70
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
34.60
-7.73%
|
37.50
+20.19%
|
31.20
-16.80%
|
37.50
|
| Total Tax Payable |
|
35.90
-15.13%
|
42.30
-15.57%
|
50.10
+11.83%
|
44.80
|
| Income Tax Payable |
|
8.90
+128.21%
|
3.90
-48.00%
|
7.50
-41.86%
|
12.90
|
| Current Debt And Capital Lease Obligation |
|
21.60
-98.24%
|
1,226.90
+5714.69%
|
21.10
-97.34%
|
793.10
|
| Current Debt |
|
—
|
1,204.40
|
—
|
772.60
|
| Other Current Borrowings |
|
—
|
1,204.40
|
—
|
772.60
|
| Current Capital Lease Obligation |
|
21.60
-4.00%
|
22.50
+6.64%
|
21.10
+2.93%
|
20.50
|
| Current Deferred Liabilities |
|
27.70
+4.14%
|
26.60
-20.83%
|
33.60
+65.52%
|
20.30
|
| Current Deferred Revenue |
|
7.70
-3.75%
|
8.00
-56.52%
|
18.40
+82.18%
|
10.10
|
| Other Current Liabilities |
|
—
|
—
|
—
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
1,451.40
+0.10%
|
1,449.90
-45.08%
|
2,639.90
+85.83%
|
1,420.60
|
| Long Term Debt And Capital Lease Obligation |
|
1,368.10
+0.56%
|
1,360.50
-47.12%
|
2,572.90
+90.32%
|
1,351.90
|
| Long Term Debt |
|
1,240.90
+0.32%
|
1,237.00
-49.18%
|
2,434.20
+103.24%
|
1,197.70
|
| Long Term Capital Lease Obligation |
|
127.20
+3.00%
|
123.50
-10.96%
|
138.70
-10.05%
|
154.20
|
| Long Term Provisions |
|
20.60
+21.18%
|
17.00
+8.28%
|
15.70
+41.44%
|
11.10
|
| Tradeand Other Payables Non Current |
|
46.60
+4.02%
|
44.80
+15.76%
|
38.70
+18.35%
|
32.70
|
| Non Current Deferred Liabilities |
|
—
|
9.50
+28.38%
|
7.40
-61.05%
|
19.00
|
| Non Current Deferred Revenue |
|
—
|
9.50
+28.38%
|
7.40
-61.05%
|
19.00
|
| Non Current Deferred Taxes Liabilities |
|
—
|
—
|
—
|
4.90
|
| Other Non Current Liabilities |
|
16.10
-41.67%
|
27.60
+430.77%
|
5.20
-11.86%
|
5.90
|
| Stockholders Equity |
|
2,746.00
+30.60%
|
2,102.60
+1.64%
|
2,068.60
-2.96%
|
2,131.80
|
| Common Stock Equity |
|
2,746.00
+30.60%
|
2,102.60
+1.64%
|
2,068.60
-2.96%
|
2,131.80
|
| Capital Stock |
|
0.40
+0.00%
|
0.40
+0.00%
|
0.40
+0.00%
|
0.40
|
| Common Stock |
|
0.40
+0.00%
|
0.40
+0.00%
|
0.40
+0.00%
|
0.40
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
410.70
+0.44%
|
408.90
+0.42%
|
407.20
+3.56%
|
393.20
|
| Ordinary Shares Number |
|
384.80
-1.51%
|
390.70
+1.38%
|
385.40
-0.23%
|
386.30
|
| Treasury Shares Number |
|
25.90
+42.31%
|
18.20
-16.51%
|
21.80
+215.94%
|
6.90
|
| Additional Paid In Capital |
|
2,281.50
+8.96%
|
2,093.80
-40.43%
|
3,514.60
+55.64%
|
2,258.10
|
| Retained Earnings |
|
2,433.90
+52.35%
|
1,597.60
+56.41%
|
1,021.40
+112.84%
|
479.90
|
| Gains Losses Not Affecting Retained Earnings |
|
115.00
+1537.50%
|
-8.00
+52.10%
|
-16.70
-43.97%
|
-11.60
|
| Treasury Stock |
|
2,084.80
+31.85%
|
1,581.20
-35.49%
|
2,451.10
+311.95%
|
595.00
|
| Other Equity Adjustments |
|
115.00
+1537.50%
|
-8.00
+52.10%
|
-16.70
-43.97%
|
-11.60
|
| Total Equity Gross Minority Interest |
|
2,746.00
+30.60%
|
2,102.60
+1.64%
|
2,068.60
-2.96%
|
2,131.80
|
| Total Capitalization |
|
3,986.90
+19.38%
|
3,339.60
-25.83%
|
4,502.80
+35.24%
|
3,329.50
|
| Working Capital |
|
1,890.80
+38.08%
|
1,369.40
-52.28%
|
2,869.90
+56.87%
|
1,829.50
|
| Invested Capital |
|
3,986.90
-12.26%
|
4,544.00
+0.91%
|
4,502.80
+9.77%
|
4,102.10
|
| Total Debt |
|
1,389.70
-46.29%
|
2,587.40
-0.25%
|
2,594.00
+20.93%
|
2,145.00
|
| Net Debt |
|
323.20
-82.39%
|
1,835.30
-1.75%
|
1,867.90
+40.66%
|
1,328.00
|
| Capital Lease Obligations |
|
148.80
+1.92%
|
146.00
-8.64%
|
159.80
-8.53%
|
174.70
|
| Net Tangible Assets |
|
2,651.00
+34.13%
|
1,976.40
+3.54%
|
1,908.90
-1.24%
|
1,932.80
|
| Tangible Book Value |
|
2,651.00
+34.13%
|
1,976.40
+3.54%
|
1,908.90
-1.24%
|
1,932.80
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
1,440.70
+45.60%
|
989.50
+32.20%
|
748.50
+11.80%
|
669.50
|
| Cash Flow From Continuing Operating Activities |
|
1,440.70
+45.60%
|
989.50
+32.20%
|
748.50
+11.80%
|
669.50
|
| Net Income From Continuing Operations |
|
836.30
+45.14%
|
576.20
+6.41%
|
541.50
+58.70%
|
341.20
|
| Depreciation Amortization Depletion |
|
251.80
+15.66%
|
217.70
+17.04%
|
186.00
+19.31%
|
155.90
|
| Depreciation |
|
219.00
+20.86%
|
181.20
+22.93%
|
147.40
+2.29%
|
144.10
|
| Amortization Cash Flow |
|
32.80
-10.14%
|
36.50
-5.44%
|
38.60
+227.12%
|
11.80
|
| Depreciation And Amortization |
|
251.80
+15.66%
|
217.70
+17.04%
|
186.00
+19.31%
|
155.90
|
| Amortization Of Intangibles |
|
32.80
-10.14%
|
36.50
-5.44%
|
38.60
+227.12%
|
11.80
|
| Other Non Cash Items |
|
-14.50
+64.81%
|
-41.20
+45.86%
|
-76.10
-286.52%
|
40.80
|
| Stock Based Compensation |
|
159.60
-6.34%
|
170.40
+13.00%
|
150.80
+19.21%
|
126.50
|
| Deferred Tax |
|
182.20
+515.98%
|
-43.80
+20.36%
|
-55.00
-154.63%
|
-21.60
|
| Deferred Income Tax |
|
182.20
+515.98%
|
-43.80
+20.36%
|
-55.00
-154.63%
|
-21.60
|
| Operating Gains Losses |
|
-78.10
-5678.57%
|
1.40
+173.68%
|
-1.90
-850.00%
|
-0.20
|
| Gain Loss On Investment Securities |
|
—
|
—
|
-1.90
-850.00%
|
-0.20
|
| Unrealized Gain Loss On Investment Securities |
|
—
|
—
|
—
|
—
|
| Change In Working Capital |
|
103.40
-4.96%
|
108.80
+3300.00%
|
3.20
-88.01%
|
26.70
|
| Change In Receivables |
|
-201.90
-476.86%
|
-35.00
+86.54%
|
-260.10
-30.12%
|
-199.90
|
| Changes In Account Receivables |
|
-201.90
-476.86%
|
-35.00
+86.54%
|
-260.10
-30.12%
|
-199.90
|
| Change In Inventory |
|
-63.70
-613.71%
|
12.40
+104.91%
|
-252.60
-612.37%
|
49.30
|
| Change In Prepaid Assets |
|
-14.80
-155.17%
|
-5.80
-130.05%
|
19.30
+114.67%
|
-131.60
|
| Change In Payables And Accrued Expense |
|
402.40
+165.26%
|
151.70
-69.88%
|
503.70
+65.91%
|
303.60
|
| Change In Accrued Expense |
|
55.40
+192.33%
|
-60.00
-261.29%
|
37.20
+337.65%
|
8.50
|
| Change In Payable |
|
347.00
+63.91%
|
211.70
-54.62%
|
466.50
+58.08%
|
295.10
|
| Change In Account Payable |
|
347.00
+63.91%
|
211.70
-54.62%
|
466.50
+58.08%
|
295.10
|
| Change In Other Working Capital |
|
-18.60
-28.28%
|
-14.50
-104.23%
|
-7.10
-233.96%
|
5.30
|
| Investing Cash Flow |
|
536.00
+358.31%
|
-207.50
+59.09%
|
-507.20
+2.74%
|
-521.50
|
| Cash Flow From Continuing Investing Activities |
|
536.00
+358.31%
|
-207.50
+59.09%
|
-507.20
+2.74%
|
-521.50
|
| Net PPE Purchase And Sale |
|
-363.50
-1.31%
|
-358.80
-51.65%
|
-236.60
+35.14%
|
-364.80
|
| Purchase Of PPE |
|
-363.50
-1.31%
|
-358.80
-51.65%
|
-236.60
+35.14%
|
-364.80
|
| Capital Expenditure |
|
-363.50
-1.31%
|
-358.80
-51.65%
|
-236.60
+35.14%
|
-364.80
|
| Net Investment Purchase And Sale |
|
898.90
+438.91%
|
166.80
+161.21%
|
-272.50
-78.10%
|
-153.00
|
| Purchase Of Investment |
|
-1,265.80
+52.37%
|
-2,657.60
+17.46%
|
-3,219.90
-41.17%
|
-2,280.80
|
| Sale Of Investment |
|
2,164.70
-23.36%
|
2,824.40
-4.17%
|
2,947.40
+38.52%
|
2,127.80
|
| Net Business Purchase And Sale |
|
—
|
0.00
|
0.00
+100.00%
|
-3.90
|
| Purchase Of Business |
|
—
|
0.00
|
0.00
+100.00%
|
-3.90
|
| Net Other Investing Changes |
|
0.60
+103.87%
|
-15.50
-915.79%
|
1.90
+850.00%
|
0.20
|
| Financing Cash Flow |
|
-1,686.40
-129.50%
|
-734.80
-130.63%
|
-318.60
+42.33%
|
-552.50
|
| Cash Flow From Continuing Financing Activities |
|
-1,686.40
-129.50%
|
-734.80
-130.63%
|
-318.60
+42.33%
|
-552.50
|
| Net Issuance Payments Of Debt |
|
-1,207.50
|
0.00
-100.00%
|
443.30
|
0.00
|
| Issuance Of Debt |
|
0.00
|
0.00
-100.00%
|
1,230.60
|
0.00
|
| Repayment Of Debt |
|
-1,207.50
|
0.00
+100.00%
|
-787.30
|
0.00
|
| Long Term Debt Issuance |
|
0.00
|
0.00
-100.00%
|
1,230.60
|
0.00
|
| Long Term Debt Payments |
|
-1,207.50
|
0.00
+100.00%
|
-787.30
|
0.00
|
| Net Long Term Debt Issuance |
|
-1,207.50
|
0.00
-100.00%
|
443.30
|
0.00
|
| Net Common Stock Issuance |
|
-471.90
+34.62%
|
-721.80
-9.02%
|
-662.10
-23.71%
|
-535.20
|
| Common Stock Payments |
|
-500.00
+33.33%
|
-750.00
-8.90%
|
-688.70
-23.49%
|
-557.70
|
| Repurchase Of Capital Stock |
|
-500.00
+33.33%
|
-750.00
-8.90%
|
-688.70
-23.49%
|
-557.70
|
| Net Other Financing Charges |
|
-7.00
+46.15%
|
-13.00
+86.97%
|
-99.80
-476.88%
|
-17.30
|
| Changes In Cash |
|
290.30
+515.04%
|
47.20
+161.06%
|
-77.30
+80.89%
|
-404.50
|
| Effect Of Exchange Rate Changes |
|
21.50
+390.54%
|
-7.40
-593.33%
|
1.50
+125.86%
|
-5.80
|
| Beginning Cash Position |
|
607.30
+7.01%
|
567.50
-11.78%
|
643.30
-38.94%
|
1,053.60
|
| End Cash Position |
|
919.10
+51.34%
|
607.30
+7.01%
|
567.50
-11.78%
|
643.30
|
| Free Cash Flow |
|
1,077.20
+70.79%
|
630.70
+23.21%
|
511.90
+68.00%
|
304.70
|
| Interest Paid Supplemental Data |
|
11.40
+0.00%
|
11.40
-8.06%
|
12.40
+1.64%
|
12.20
|
| Income Tax Paid Supplemental Data |
|
94.40
-52.32%
|
198.00
-6.74%
|
212.30
+85.90%
|
114.20
|
| Common Stock Issuance |
|
28.10
-0.35%
|
28.20
+6.02%
|
26.60
+18.22%
|
22.50
|
| Earnings Losses From Equity Investments |
|
-78.10
-5678.57%
|
1.40
+173.68%
|
-1.90
|
—
|
| Issuance Of Capital Stock |
|
28.10
-0.35%
|
28.20
+6.02%
|
26.60
+18.22%
|
22.50
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-16 View
- 42026-03-18 View
- 42026-03-10 View
- 42026-03-10 View
- 42026-03-10 View
- 42026-03-10 View
- 42026-03-10 View
- 42026-03-10 View
- 8-K2026-03-02 View
- 42026-02-26 View
- 8-K2026-02-26 View
- 42026-02-17 View
- 10-K2026-02-12 View
- 8-K2026-02-12 View
- 42026-02-02 View
- 42026-02-02 View
- 42026-02-02 View
- 42026-02-02 View
- 42026-02-02 View
- 8-K2026-01-12 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|